E Hatva

943 total citations
8 papers, 786 citations indexed

About

E Hatva is a scholar working on Cancer Research, Molecular Biology and Oncology. According to data from OpenAlex, E Hatva has authored 8 papers receiving a total of 786 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Cancer Research, 4 papers in Molecular Biology and 2 papers in Oncology. Recurrent topics in E Hatva's work include Cancer, Hypoxia, and Metabolism (4 papers), Angiogenesis and VEGF in Cancer (3 papers) and Soft tissue tumor case studies (2 papers). E Hatva is often cited by papers focused on Cancer, Hypoxia, and Metabolism (4 papers), Angiogenesis and VEGF in Cancer (3 papers) and Soft tissue tumor case studies (2 papers). E Hatva collaborates with scholars based in Finland, Sweden and Italy. E Hatva's co-authors include Kari Alitalo, Matti Haltia, Arja Kaipainen, Juha E. Jääskeläinen, M. Graziella Persico, Tom Böhling, Athina Lymboussaki, Erja Halmesmäki, Vladimir Joukov and Piia Vuorela and has published in prestigious journals such as British Journal of Cancer, The American Journal of Surgical Pathology and Biology of Reproduction.

In The Last Decade

E Hatva

8 papers receiving 766 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
E Hatva Finland 8 475 223 178 162 106 8 786
Valeria Vincenti Italy 5 586 1.2× 199 0.9× 166 0.9× 163 1.0× 20 0.2× 6 860
Victoria A. Robb United States 12 518 1.1× 85 0.4× 60 0.3× 132 0.8× 78 0.7× 14 872
S Vera Canada 6 635 1.3× 150 0.7× 81 0.5× 321 2.0× 52 0.5× 8 1.3k
Herman Van den Berghe Belgium 10 302 0.6× 130 0.6× 111 0.6× 71 0.4× 21 0.2× 12 708
Petra Reusch Germany 12 521 1.1× 178 0.8× 50 0.3× 212 1.3× 24 0.2× 16 877
Wolfgang Röckl Germany 8 718 1.5× 172 0.8× 80 0.4× 206 1.3× 11 0.1× 10 1.0k
Rosa Maria Alfano Italy 14 276 0.6× 109 0.5× 43 0.2× 207 1.3× 35 0.3× 25 635
Bernd Kazmierczak Germany 24 617 1.3× 265 1.2× 232 1.3× 179 1.1× 19 0.2× 58 1.5k
C. de Vries Netherlands 8 861 1.8× 467 2.1× 64 0.4× 196 1.2× 29 0.3× 9 1.3k

Countries citing papers authored by E Hatva

Since Specialization
Citations

This map shows the geographic impact of E Hatva's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E Hatva with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E Hatva more than expected).

Fields of papers citing papers by E Hatva

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E Hatva. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E Hatva. The network helps show where E Hatva may publish in the future.

Co-authorship network of co-authors of E Hatva

This figure shows the co-authorship network connecting the top 25 collaborators of E Hatva. A scholar is included among the top collaborators of E Hatva based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E Hatva. E Hatva is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Vuorela, Piia, E Hatva, Athina Lymboussaki, et al.. (1997). Expression of Vascular Endothelial Growth Factor and Placenta Growth Factor in Human Placenta1. Biology of Reproduction. 56(2). 489–494. 212 indexed citations
2.
Hatva, E, Tom Böhling, Juha E. Jääskeläinen, et al.. (1996). Vascular growth factors and receptors in capillary hemangioblastomas and hemangiopericytomas. The American Journal of Surgical Pathology. 148. 763–775. 16 indexed citations
3.
Hatva, E, Juha E. Jääskeläinen, Harri Hirvonen, Kari Alitalo, & Matti Haltia. (1996). Tie Endothelial Cell-specific Receptor Tyrosine Kinase Is Upregulated in the Vasculature of Arteriovenous Malformations. Journal of Neuropathology & Experimental Neurology. 55(11). 1124–1133. 87 indexed citations
4.
Böhling, Tom, E Hatva, Minna Kujala, et al.. (1996). Expression of Growth Factors and Growth Factor Receptors in Capillary Hemangioblastoma. Journal of Neuropathology & Experimental Neurology. 55(5). 522–527. 75 indexed citations
5.
Lymboussaki, Athina, Arja Kaipainen, E Hatva, et al.. (1996). Expression of Mad, an antagonist of Myc oncoprotein function, in differentiating keratinocytes during tumorigenesis of the skin. British Journal of Cancer. 73(11). 1347–1355. 24 indexed citations
6.
Hatva, E, Tom Böhling, Juha E. Jääskeläinen, et al.. (1996). Vascular growth factors and receptors in capillary hemangioblastomas and hemangiopericytomas.. PubMed. 148(3). 763–75. 102 indexed citations
7.
Hatva, E, Arja Kaipainen, Panu Mentula, et al.. (1995). Expression of endothelial cell-specific receptor tyrosine kinases and growth factors in human brain tumors.. PubMed. 146(2). 368–78. 171 indexed citations
8.
Kaipainen, Arja, Tatyana Vlaykova, E Hatva, et al.. (1994). Enhanced expression of the tie receptor tyrosine kinase mesenger RNA in the vascular endothelium of metastatic melanomas.. PubMed. 54(24). 6571–7. 99 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026